Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Omics Analysis Reveals Impacts of SCARB1, TYR, and TYRP1 Knockouts on Pigmentation and Metabolic Pathways in Oujiang Color Common Carp.

Animal genetics·2026
Same author

ScQCenrich enables multi-metric quality control for single-cell RNA sequencing.

Communications biology·2026
Same author

Pharmacoeconomic Evaluation of Netupitant Palonosetron for Chemotherapy-Induced Nausea and Vomiting: Evidence from Economic Analyses.

Therapeutic innovation & regulatory science·2026
Same author

Comparative brain transcriptomics reveals neural regulatory networks underlying heterosis in crucian carp hybrids.

Genomics·2026
Same author

Moderate warming promotes growth and flavonoid biosynthesis in the altitudinal medicinal plant <i>Gentiana lawrencei</i> var. <i>farreri</i>.

Frontiers in plant science·2026
Same author

Nonlinear modal evolution of microbubbles confined by rigid capillary constraint.

Ultrasonics sonochemistry·2026

Related Experiment Video

Updated: May 7, 2025

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.3K

PLK1 inhibition impairs erythroid differentiation.

Peijun Jia1, Yan Li1, Lulu Duan1

  • 1School of Life Sciences, Zhengzhou University, Zhengzhou, China.

Frontiers in Cell and Developmental Biology
|January 7, 2025
PubMed
Summary

Polo-like kinase 1 (PLK1) inhibitors cause anemia by harming red blood cell development. This study reveals PLK1 is crucial for erythropoiesis, explaining why these cancer drugs induce anemia.

Keywords:
anemiaapoptosiscell cycleerythropoiesisplk1

More Related Videos

Analysis of Hematopoietic Stem Progenitor Cell Metabolism
12:20

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Published on: November 9, 2019

6.7K
Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.1K

Related Experiment Videos

Last Updated: May 7, 2025

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.3K
Analysis of Hematopoietic Stem Progenitor Cell Metabolism
12:20

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Published on: November 9, 2019

6.7K
Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.1K

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Polo-like kinase 1 (PLK1) is overexpressed in many cancers and is a target for cancer therapy.
  • PLK1 inhibitors can cause anemia, but the mechanisms are not well understood.

Purpose of the Study:

  • To investigate the impact of PLK1 inhibitors on erythropoiesis.
  • To elucidate the mechanisms underlying PLK1 inhibitor-induced anemia.

Main Methods:

  • Used an in vitro erythroid differentiation system with human CD34+ cells.
  • Employed a murine model to study anemia in vivo.
  • Assessed cell proliferation, cell cycle, apoptosis, and red blood cell parameters.

Main Results:

  • PLK1 inhibitors (GSK461364, BI6727) suppressed erythroid cell proliferation and induced G2/M arrest and apoptosis.
  • In vivo, PLK1 inhibition led to severe anemia with reduced red blood cells and hemoglobin.
  • PLK1 inhibition impaired hematopoietic stem cell differentiation, affecting BFU-E and CFU-E cells, and reducing terminal erythrocytes.

Conclusions:

  • PLK1 plays a critical role in erythropoiesis.
  • PLK1 inhibitors induce anemia by promoting erythroid cell apoptosis and cell cycle arrest.
  • Findings provide guidance for managing anemia in PLK1-targeted cancer therapies.